Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01113112 · ClinicalTrials.gov registry record
Biobehavioral-Cytokine Interactions in Ovarian Cancer
A clinical trial of Ovarian Neoplasms, sponsored by Susan Lutgendorf.
- Completed
- Registry status
- 613
- Enrollment target
- 2
- Study locations
NCT01113112 is a study of Ovarian Neoplasms that has completed, run by Susan Lutgendorf. The registered enrollment target is 613 participants, above the 352-participant average among 38 other Ovarian Neoplasms trials with a reported enrollment target (74% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT01113112, a study of Ovarian Neoplasms, has completed, sponsored by Susan Lutgendorf.
- COMPLETED
- Registry status
- 613 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to understand relationships between behavioral factors, hormones, and chemicals produced by the body that may help tumor growth in ovarian cancer.
Conditions Studied
Study Locations (2)
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 613 participants |
| Start Date | 2003-08 |
| Est. Completion | 2026-01-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01113112
The ClinicalTrials.gov registry entry for NCT01113112 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 613 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 352-participant average among 38 other Ovarian Neoplasms trials with a reported enrollment target (74% higher). The listed sponsor is Susan Lutgendorf, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ovarian Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT01113112 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Iowa, Missouri.
Frequently Asked Questions
What is clinical trial NCT01113112 about?
NCT01113112 is a clinical study titled "Biobehavioral-Cytokine Interactions in Ovarian Cancer". The purpose of this study is to understand relationships between behavioral factors, hormones, and chemicals produced by the body that may help tumor growth in ovarian cancer.
What is the current status of trial NCT01113112?
This trial is currently completed. The enrollment target is 613 participants. The study started on 2003-08. Estimated completion is 2026-01-02.
What conditions does trial NCT01113112 study?
This clinical trial studies the following conditions: Ovarian Neoplasms.
Who is sponsoring clinical trial NCT01113112?
This trial is sponsored by Susan Lutgendorf, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01113112 being conducted?
This trial has 2 study locations across Iowa, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RECRUITING · Phase 1
-
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
RECRUITING
-
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RECRUITING · Phase 1
-
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
RECRUITING · NA
-
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.